2014 - 2017 Development of nuclear medical imaging probes targeting cerebral amyloid antipathy
Papers (45):
Shimpei Iikuni, Yuta Tarumizu, Shohei Tsuchihashi, Takaki Ohara, Hiroyuki Watanabe, Masahiro Ono. Synthesis and Evaluation of Novel 111In-Labeled Picolinic Acid-Based Radioligands Containing an Albumin Binder for Development of a Radiotheranostic Platform. Molecular Pharmaceutics. 2022. 19. 8. 2725-2736
Shimpei Iikuni, Takaki Ohara, Hiroyuki Watanabe, Masahiro Ono. Structure-Activity Relationships and Pharmacokinetics of 111In-Labeled Glucagon-like Peptide-1 Receptor-Targeting Exendin-4 Derivatives Conjugated with Albumin Binder Moieties. Molecular Pharmaceutics. 2022. 19. 8. 2832-2839
北野杏奈, 飯國慎平, 渡邊裕之, 玉田太郎, 小野正博. Development of nuclear medicine imaging probe targeting granzyme B to predict effect of immune checkpoint inhibitors: synthesis and evaluation of novel radioiodine-labeled tetrapeptides. 日本薬学会年会要旨集(Web). 2021. 141st